Granulocyte Colony-Stimulating Factor Administration at 1 Hour Before 18F-FDG PET Does Not Increase Bone Marrow FDG Accumulation

Clin Nucl Med. 2021 Sep 1;46(9):770-771. doi: 10.1097/RLU.0000000000003649.

Abstract

A 74-year-old man with diffuse large B-cell lymphoma underwent 18F-FDG PET/CT to evaluate the response to chemotherapy. Although granulocyte colony-stimulating factor was incidentally administered 1 hour before FDG administration, bone marrow FDG accumulation did not increase compared with the previous 18F-FDG PET/CT examination without granulocyte colony-stimulating factor administration. The mean SUVmax of 12 thoracic and 5 lumbar vertebrae was 2.55 (range, 2.14-3.36) and 3.19 (range, 2.49-4.28) in the present and previous examinations, respectively.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bone Marrow* / diagnostic imaging
  • Fluorodeoxyglucose F18*
  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Granulocyte Colony-Stimulating Factor